{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:19:57Z","timestamp":1791983997330,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jhep.2022.02.022","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T15:31:51Z","timestamp":1646667111000},"page":"365-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Performance of routine risk scores for predicting cirrhosis-related morbidity in the community"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0565-1083","authenticated-orcid":false,"given":"Hamish","family":"Innes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-2893","authenticated-orcid":false,"given":"Joanne R.","family":"Morling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2421-6127","authenticated-orcid":false,"given":"Stephan","family":"Buch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Hamill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Stickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6940-5861","authenticated-orcid":false,"given":"Indra Neil","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2022.02.022_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2022.02.022_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.puhe.2020.07.017","article-title":"Late diagnosis of chronic liver disease in a community cohort (UK biobank): determinants and impact on subsequent survival","volume":"187","author":"Innes","year":"2020","journal-title":"Public Helath"},{"key":"10.1016\/j.jhep.2022.02.022_bib3","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(14)61838-9","article-title":"Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity and viral hepatitis","volume":"384","author":"Williams","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2022.02.022_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: protecting he next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2022.02.022_bib5","doi-asserted-by":"crossref","first-page":"J2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2022.02.022_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/liv.14669","article-title":"Prognostic accuracy of FIB-4 NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review","volume":"41","author":"Lee","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2022.02.022_bib7","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jhep.2021.05.008","article-title":"Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease","volume":"75","author":"Younes","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.02.022_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jhep.2016.08.011","article-title":"The genetics of alcohol dependence and alcohol-related liver disease","volume":"66","author":"Stickel","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.02.022_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2021.10.005","article-title":"A\u00a0genetic risk score and diabetes predicts development of alcohol-related cirrhosis in drinkers","volume":"76","author":"Whitfield","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.02.022_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","article-title":"Non-invasive stratification of hepatocellular carcinoma in non-alcoholic fatty liver using polygenic risk scores","volume":"74","author":"Bianco","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.02.022_bib11","doi-asserted-by":"crossref","first-page":"E1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex disease of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.jhep.2022.02.022_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007516","article-title":"Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilizing transient elastography","volume":"5","author":"Harman","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhep.2022.02.022_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208798","article-title":"Local care and treatment of liver disease (LOCATE) \u2013 a cluster-randomized feasibility study to discover, access and manage early liver disease in primary care","volume":"13","author":"El-Gohary","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2022.02.022_bib14","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.cgh.2017.12.048","article-title":"High prevalence of liver fibrosis among Europeans adults with unknown liver disease: a population-based study","volume":"16","author":"Caballeria","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2022.02.022_bib15","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ueg2.12109","article-title":"High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort","volume":"9","author":"Llop","year":"2021","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jhep.2022.02.022_bib16","series-title":"UK Chief Medical Officers\u2019 alcohol guidelines review. Summary of the proposed new guidelines","year":"2016"},{"key":"10.1016\/j.jhep.2022.02.022_bib17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/ajg.2015.191","article-title":"Causes of death in people with liver cirrhosis in England compared with the general population: a population-based cohort study","volume":"110","author":"Ratib","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2022.02.022_bib18","unstructured":"Fry D, Almond R, Moffat S, Gordon M, Singh P. UK Biobank project. Companion document to accompany serum biomarker data. Version 1.0. Date 11\/3\/2019. https:\/\/biobank.ndph.ox.ac.uk\/showcase\/ukb\/docs\/serum_biochemistry.pdf. Accessed January\u00a02022."},{"key":"10.1016\/j.jhep.2022.02.022_bib19","unstructured":"Sheard SM, Nicholls R, Froggatt J. UK Biobank Haematology Data Companion Document. Date: 24\/10\/17. https:\/\/biobank.ndph.ox.ac.uk\/showcase\/ukb\/docs\/haematology.pdf. Accessed January\u00a02022."},{"key":"10.1016\/j.jhep.2022.02.022_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/hep.27598","article-title":"The clinical course of cirrhosis: the importance of multistate models and competing risks analysis","volume":"62","author":"Jepsen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.02.022_bib21","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2022.02.022_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/EDE.0b013e3181a39056","article-title":"Prognostic models with competing risks. Methods and application to coronary risk prediction","volume":"20","author":"Wolbers","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.jhep.2022.02.022_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2288-8-79","article-title":"Under reliance on I2 in assessing heterogeneity may mislead","volume":"8","author":"Rucker","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jhep.2022.02.022_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2022.02.022_bib25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/ije\/28.5.964","article-title":"The use of fractional polynomials to model continuous risk variables in epidemiology","volume":"28","author":"Royston","year":"1999","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jhep.2022.02.022_bib26","series-title":"Regression modelling strategies","author":"Harrell","year":"2001"},{"key":"10.1016\/j.jhep.2022.02.022_bib27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis- 2021 update","volume":"75","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.02.022_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044952","article-title":"Can routine blood tests be modelled to detect advanced liver disease in the community: model derivation and validation using UK primary and secondary care data","volume":"11","author":"Hydes","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhep.2022.02.022_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2017-314924","article-title":"Guidelines on the management of abnormal liver blood tests","volume":"67","author":"Newsome","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.02.022_bib30","unstructured":"National Institute for Health and Care Excellence (NICE). NICE Guideline. Non-alcoholic fatty liver disease (NAFLD): assessment and management. Available at: https:\/\/www.nice.org.uk\/guidance\/ng49. Accessed October 2021.."},{"key":"10.1016\/j.jhep.2022.02.022_bib31","article-title":"A\u00a0polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores","author":"De Vincentis","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2022.02.022_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41586-020-2314-9","article-title":"Variability in the analysis of a single neuroimaging dataset by many teams","volume":"582","author":"Botvinik-Nexer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2022.02.022_bib33","unstructured":"UK Biobank. Biomarker assay quality procedures: approaches used to minimise systematic and random errors (and the wider epidemiological implications). Version 1.2. Available at: https:\/\/biobank.ctsu.ox.ac.uk\/crystal\/crystal\/docs\/biomarker_issues.pdf. Accessed: December 2021."},{"key":"10.1016\/j.jhep.2022.02.022_bib34","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jhep.2022.02.022_bib35","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1038\/s41598-019-39998-2","article-title":"Rare pathogenic variants predispose to hepatocellular carcinoma in non-alcoholic fatty liver disease","volume":"9","author":"Pelusi","year":"2019","journal-title":"Sci Rep"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822001295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822001295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:45:24Z","timestamp":1759175124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827822001295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0168827822001295"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2022.02.022","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of routine risk scores for predicting cirrhosis-related morbidity in the community","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2022.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}